MRD / Regn No. : THBC\23-24\05691 Date : 21/07/2026
Patient Name : Surinder Sachdeva Age & Gender : 62 Yrs. / Male
Contact No. : 8398981121 UHID :
Ht / Wt / BMI : 166 / 80.55 / 29.23 BP S / BP D : /
Allergies : NONE Referred By :
   
Problem List : T2DM (26/Nov/2018) |
Subjective : T2DM SINCE 2018,CHRONIC PANCREATITIS / CLD / REC UTI / CKD,LEFT SCIATICA,ENZAR HS - ACIDITY SETTLED,GLP1 ANALOGS - PANCREATITIS / ACIDITY,AFTER LSM - SUGARS DROPPED FROM 150 TO 100 / PPBS 250/300 TO 200 MG,BURNING BETTER / NUMBNESS+
Objective : 07-JUL-2026 REPORTS,FBS-108,ALT-20/ AST-25,ACR-643.51,CR-2.18,EGFR-33,NA- 131/ K-5.42/ CL-100,HSCRP-4.32,HBA1C-7.1%,FT3-2.52/ FT4-0.92/ TSH-3.100,CORTISOL (8AM)-12.80,HB-11.7,TC-158/ TG-173/ LDL-88/ HDL-36,VITB12- < 2000,VITD-37.70,T PSA-2.47
Analysis : TAMSULOSIN / HALOPERIDOL / SOBISIS / ZOLFRESH / CRANAC D / EPTOIN / CORTEL LN / SAZO / ZONALTA
Plan : TO TAKE INSULIN DOSES 15-20 MINS BEFORE MEAL (HUMALOG U 200),TRESIBA AT NIGHT ONLY  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TRESIBA SC 0-0-0-15 BEDTIME
30 DAYS
2 PREGABA 75 MG ORAL 1-0-1-0 ABF / EVENING 7 PM
TO CONTINUE
3 TABLET DULOXETINE 20 MG
DULANE 20 MG
ORAL 0-1-0 AL
TO CONTINUE
4 DOLO 500 ORAL 1-0-1 ABF / AD
3-5 DAYS
5 EPTOIN 100 MG ORAL 1-0-1 ABF / AD
TO CONTINUE
6 SOBISIS FORTE ORAL 1-0-1 ABF/AD
TO CONTINUE
7 CORTEL LN 40 ORAL 1-0-1 ABF / AD
TO CONTINUE
8 URIMAX 0.4 MG ORAL 0-0-1 AD
TO CONTINUE
9 BILYSPA 4 MG ORAL 0-0-1 AD
TO CONTINUE
10 NEBISTAR 2.5 MG ORAL 1-0-0 ABF
TO CONTINUE
11 HUMALOG U 200 SC 10-18-16-10-16 UNITS BEFORE EACH MEAL 15-20 MINS
30 DAYS
12 TABLET ACARBOSE 50 MG
GLUCOBAY 50 MG
Medicine For DIABETES
ORAL 1 TAB SOS WITH COFFEE/ PROTEIN
TO CONTINUE
       
Refill : 0 / Substitution:    
Education : IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.
Next Visit : 30/Aug/2026
Tests Suggested For Next Visit : FBS / PPBS / HBA1C > 40 DAYS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: